HPV testing is not useful for LSIL Triage - But stay tuned: Commentary

Advances in Anatomic Pathology

Volumn 8, Issue 3, 2001, Pages 160-164

  Stoler, Mark H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Atypical Squamous Cells of Undetermined Significance Low Grade Squamous Intraepithelial Lesions Triage Study (ALTS); Cervical intraepithelial lesion (CIN) I; Human papillomavirus (HPV); LSIL; Triage

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLASSIFICATION; DNA PROBE; EMERGENCY HEALTH SERVICE; EVALUATION; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MASS SCREENING; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PROBES, HPV; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TRIAGE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0035347159     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200105000-00004     Document Type: Note

References (21)

1. Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol 2000;44(5):726-42.
2. Kurman RJ, Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy. New York: Springer-Verlag; 1994.
3. Sherman ME, Schiffman MH, Erozan YS, et al. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses. Arch Pathol Lab Med 1992;116(11):1155-8.
4. Cavuslu S, Mant C, Starkey WG, et al. Analytic sensitivities of hybrid-capture, consensus and type-specific polymerase chain reactions for the detection of human papillomavirus type 16 DNA. J Med Virol 1996;49(4):319-24. (Pubitemid 26301105)
5. Cope JU, Hildesheim A, Schiffman MH, et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol 1997;35(9):2262-5. (Pubitemid 27349792)
6. Cox JT. Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings [editorial; comment]. JAMA 1999;281(17):1645-7. (Pubitemid 29211777)
7. Cox JT, Lorincz AT, Schiffman MH, et al. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172(3):946-54.
8. Lorincz AT. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996;22(6):629-36.
9. Schiffman MH, Schatzkin A. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia [see comments]. Cancer Res 1994;54(7 Suppl):1944s-7s. (Pubitemid 24132152)
10. Schiffman MH, Kiviat NB, Burk RD, et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 1995;33(3):545-50.
11. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica [see comments]. JAMA 2000;283(1):87-93. (Pubitemid 30038388)
12. Cox JT. HPV testing: is it useful in triage of minor Pap abnormalities? [editorial; comment]. J Fam Pract 1998;46(2):121-4.
13. Manos MM, Kinney WK, Hurley LB, et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results [see comments]. JAMA 1999;281(17):1605-10. (Pubitemid 29211769)
14. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group [see comments]. J Natl Cancer Inst 2000;92(5):397-402.
15. Richart RM, Masood S, Syrjanen KJ, et al. Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial. Acta Cytol 1998;42(1):50-8.
16. Stoler MH. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int J Gynecol Pathol 2000;19(1):16-28. (Pubitemid 30010639)
17. Stoler MH. Advances in cervical screening technology. Mod Pathol 2000;13(3):275-84. (Pubitemid 30207512)
18. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102(5A):3-8. (Pubitemid 127695953)
19. Kjaer SK, van den Brule AJ, Bock JE, et al. Human papillomavirus-the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 1996;65(5):601-6. (Pubitemid 26092288)
20. Schiffman MH. New epidemiology of human papillomavirus infection and cervical neoplasia [editorial; comment]. J Natl Cancer Inst 1995;87(18):1345-7.
21. Sherman ME, Schiffman MH, Lorincz AT, et al. Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol 1994;102(2):182-7. (Pubitemid 24320521)